Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike Protein

Matthijs P. Raadsen, Christine Dahlke, Anahita Fathi, Mart M. Lamers, Petra van den Doel, Luca M. Zaeck, Martin E. van Royen, Erwin de Bruin, Reina Sikkema, Marion Koopmans, Eric C. M. van Gorp, Gerd Sutter, Rory D. de Vries, Marylyn M. Addo, Bart L. Haagmans*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)
59 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike Protein'. Together they form a unique fingerprint.

Immunology and Microbiology